Medical abortion: Defining success and categorizing failures

Contraception

Volumn 68, Issue 4, 2003, Pages 247-251

  Rørbye, Christina ^a   Nørgaard, Mogens ^a   Vestermark, Vibeke ^a   Nilas, Lisbeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Definition; Failure; Long term success rate; Medical abortion; Success; hCG

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; GEMEPROST; MIFEPRISTONE;

ARTICLE; CLINICAL TRIAL; CURETTAGE; DRUG EFFICACY; ENDOMETRIUM; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0142188599     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00175-6     Document Type: Article

References (21)

1. Kahn J., Becker B., MacIsaa L., et al. The efficacy of medical abortion a meta-analysis . Contraception. 61:2000;29-40.
2. Scheepers H., van Erp E., van den Berg A. Use of misoprostol in first and second trimester abortion review . Obstet Gynecol Surv. 54:1999;592-600.
3. Grimes D.A. Medical abortion in early pregnancy a review of the evidence . Obstet Gynecol. 89:1997;790-796.
4. Schaff E.A., Fielding S.L., Westhoff C., et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. JAMA. 284:2000;1948-1953.
5. Schaff E.A., Eisinger S.H., Stadalius L.S., Franks P., Gore B.Z., Poppemas S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 59:1999;1-6.
6. Spitz I.M., Bardin C.W., Benton L., Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 338:1998;1241-1247.
7. Ashok P.W., Penney G.C., Flett G.M.M., Templeton A. An effective regimen for early abortion a report of 2000 consecutive cases . Hum Reprod. 13:1998;2962-2965.
8. Aubeny E., Peyron R., Turpin C.L., et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU486) and increasing doses of misoprostol. Int J Fertil. 40:1995;85-91.
9. Trussel J., Ellertson C. Estimating the efficacy of medical abortion. Contraception. 60:1999;119-135.
10. Knudsen U.B. First trimester abortion with mifepristone and vaginal misoprostol. Contraception. 63:2001;247-250.
11. Termination of pregnancy with reduced doses of mifepristone. Br Med J. 307:1993;523-527.
12. Urquhart D.R., Templeton A.A., Shinewi F., et al. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study - final results. Contraception. 55:1997;1-5.
13. Creinin M.D., Carbonell J.L.L., Schwartz J.L., Varela L., Tanda R. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception. 59:1999;11-16.
14. Aubeny E., Chatellier G. A randomised comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. Eur J Contracept Health Care. 5:2000;171-176.
15. Nielsen S., Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet. 345:1995;84-86.
16. Winikoff B., Ellertson C., Clark S. Analysis of failure in medical abortion. Contraception. 54:1996;323-327.
17. Allen R., Westhof C., De Nonno L., Fielsding S., Schaff E. Curettage after mifepristone-induced abortion frequency, timing, and indications . Obstet Gynecol. 98:2001;101-106.
18. Lähteenmäki P. The disappearance of hCG and return of pituitary function after abortion. Clin Endocrinol. 9:1978;101-112.
19. Marrs R.P., Kletsky O.A., Howard W.F., Mishell D.R. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol. 135:1979;731-736.
20. Steier J.A., Bergsjø P., Myking O.L. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy. Obstet Gynecol. 64:1984;391-394.
21. van der Lugt B., Drogendijk A.C. The disappearance of human chorionic gonadotropin from plasma and urine following induced abortion. Acta Obstet Gynecol Scand. 64:1985;547-552.